Siemens Healthineers (OTCMKTS:SMMNY) Issues Quarterly Earnings Results

Siemens Healthineers (OTCMKTS:SMMNY) released its quarterly earnings results on Friday. The company reported $0.41 earnings per share for the quarter, topping the consensus estimate of $0.30 by $0.11, Zacks reports.

Siemens Healthineers Price Performance

OTCMKTS SMMNY traded down $0.13 on Friday, reaching $21.38. 125,212 shares of the stock were exchanged, compared to its average volume of 159,718. Siemens Healthineers has a one year low of $19.20 and a one year high of $28.92. The company’s 50-day simple moving average is $19.94 and its two-hundred day simple moving average is $21.82.

Analyst Ratings Changes

Separately, Zacks Research lowered Siemens Healthineers from a “hold” rating to a “strong sell” rating in a research note on Friday, May 15th. One research analyst has rated the stock with a Strong Buy rating, two have given a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy”.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.